JP2008540398A5 - - Google Patents

Download PDF

Info

Publication number
JP2008540398A5
JP2008540398A5 JP2008509538A JP2008509538A JP2008540398A5 JP 2008540398 A5 JP2008540398 A5 JP 2008540398A5 JP 2008509538 A JP2008509538 A JP 2008509538A JP 2008509538 A JP2008509538 A JP 2008509538A JP 2008540398 A5 JP2008540398 A5 JP 2008540398A5
Authority
JP
Japan
Prior art keywords
oligosaccharide
unit
mannose
formula
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2008509538A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008540398A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2006/001703 external-priority patent/WO2006120576A2/en
Publication of JP2008540398A publication Critical patent/JP2008540398A/ja
Publication of JP2008540398A5 publication Critical patent/JP2008540398A5/ja
Withdrawn legal-status Critical Current

Links

JP2008509538A 2005-05-06 2006-05-08 髄膜炎a型ワクチンのための免疫原 Withdrawn JP2008540398A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67828905P 2005-05-06 2005-05-06
PCT/IB2006/001703 WO2006120576A2 (en) 2005-05-06 2006-05-08 Immunogens for meningitidis-a vaccines

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013079295A Division JP5699174B2 (ja) 2005-05-06 2013-04-05 髄膜炎a型ワクチンのための免疫原

Publications (2)

Publication Number Publication Date
JP2008540398A JP2008540398A (ja) 2008-11-20
JP2008540398A5 true JP2008540398A5 (cg-RX-API-DMAC10.html) 2009-06-25

Family

ID=36942242

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008509538A Withdrawn JP2008540398A (ja) 2005-05-06 2006-05-08 髄膜炎a型ワクチンのための免疫原
JP2013079295A Expired - Fee Related JP5699174B2 (ja) 2005-05-06 2013-04-05 髄膜炎a型ワクチンのための免疫原

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013079295A Expired - Fee Related JP5699174B2 (ja) 2005-05-06 2013-04-05 髄膜炎a型ワクチンのための免疫原

Country Status (15)

Country Link
US (1) US8062641B2 (cg-RX-API-DMAC10.html)
EP (1) EP1885734B1 (cg-RX-API-DMAC10.html)
JP (2) JP2008540398A (cg-RX-API-DMAC10.html)
CN (1) CN101282984B (cg-RX-API-DMAC10.html)
AU (1) AU2006245440B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI0611447A2 (cg-RX-API-DMAC10.html)
CA (1) CA2606890C (cg-RX-API-DMAC10.html)
ES (1) ES2533248T3 (cg-RX-API-DMAC10.html)
MX (1) MX2007013881A (cg-RX-API-DMAC10.html)
NZ (1) NZ563940A (cg-RX-API-DMAC10.html)
PL (1) PL1885734T3 (cg-RX-API-DMAC10.html)
PT (1) PT1885734E (cg-RX-API-DMAC10.html)
RU (1) RU2412944C2 (cg-RX-API-DMAC10.html)
WO (1) WO2006120576A2 (cg-RX-API-DMAC10.html)
ZA (1) ZA200710558B (cg-RX-API-DMAC10.html)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX339524B (es) 2001-10-11 2016-05-30 Wyeth Corp Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
HUE045482T2 (hu) 2005-06-27 2019-12-30 Glaxosmithkline Biologicals Sa Immunogén készítmény
AR064642A1 (es) 2006-12-22 2009-04-15 Wyeth Corp Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
AU2014200640B2 (en) * 2007-01-11 2016-06-16 Glaxosmithkline Biologicals Sa Modified saccharides
GB0700562D0 (en) * 2007-01-11 2007-02-21 Novartis Vaccines & Diagnostic Modified Saccharides
ES2584927T7 (es) 2007-10-16 2020-11-05 Progen Pg500 Series Pty Ltd Derivados de oligosacáridos sulfatados novedosos
CA2808975C (en) 2010-08-23 2018-10-30 Wyeth Llc Stable formulations of neisseria meningitidis rlp2086 antigens
EP2612148B1 (en) 2010-09-04 2019-06-12 GlaxoSmithKline Biologicals SA Bactericidal antibody assays to assess immunogenicity and potency of meningococcal capsular saccharide vaccines
KR101584871B1 (ko) 2010-09-10 2016-01-22 와이어쓰 엘엘씨 네이세리아 메닝기티디스 orf2086 항원의 비-지질화된 변이체
CN102417521B (zh) * 2010-09-28 2014-05-07 中国医学科学院医药生物技术研究所 一种非环核苷类抗病毒药物磷酸单酯化合物的制备方法
US10010616B2 (en) 2011-01-28 2018-07-03 Purdue Research Foundation Immunogenic compositions and reagents for preparing
US9616139B2 (en) 2011-07-12 2017-04-11 The General Hospital Corporation Conjugating amines
RU2476444C1 (ru) * 2011-07-15 2013-02-27 Российская Федерация, от имени которой выступает Министерство промышленности и торговли Российской Федерации (Минпромторг России) СПОСОБ ПОЛУЧЕНИЯ КОНЪЮГАТА НОНА-β-(1→3)-ГЛЮКОЗИДА С БЫЧЬИМ СЫВОРОТОЧНЫМ АЛЬБУМИНОМ СКВАРАТНЫМ МЕТОДОМ
CA2865745C (en) 2012-03-09 2018-01-09 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
SA115360586B1 (ar) 2012-03-09 2017-04-12 فايزر انك تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
EP2958905B1 (en) 2013-02-22 2017-03-29 Amgen Inc. Carbohydrate phosphonate derivatives as modulators of glycosylation
CA2903716C (en) 2013-03-08 2019-04-09 Pfizer Inc. Immunogenic fusion polypeptides
JP6416249B2 (ja) * 2013-07-07 2018-10-31 マックス プランク ゲゼルシャフト ツゥアー フェデルゥン デル ヴィッセンシャフテン エー フォー ストレプトコッカス ニューモニエ1型に対する合成ワクチン
RU2662968C2 (ru) 2013-09-08 2018-07-31 Пфайзер Инк. Иммуногенная композиция против neisseria meningitidis (варианты)
KR20160124802A (ko) * 2014-02-25 2016-10-28 엠에스디 웰컴 트러스트 힐레맨 랩스 피브이티. 리미티드 네이세리아 메닝기티디스 혈청군 x의 신규한 합성 올리고머 및 이의 제조 방법
TN2017000126A1 (en) * 2014-10-09 2018-10-19 Msd Wellcome Trust Hilleman Laboratories Pvt Ltd An improved process of conjugation and novel synthetic oligosaccharide- protein conjugates obtained thereof
KR20190049940A (ko) 2015-02-19 2019-05-09 화이자 인코포레이티드 나이세리아 메닌지티디스 조성물 및 그의 방법
CN109890413B (zh) 2016-09-02 2024-04-16 赛诺菲巴斯德股份有限公司 脑膜炎奈瑟氏菌疫苗
SG11201906519RA (en) 2017-01-31 2019-08-27 Pfizer Neisseria meningitidis compositions and methods thereof
WO2018173068A1 (en) * 2017-03-21 2018-09-27 Msd Wellcome Trust Hilleman Laboratories Pvt. Ltd. A novel synthetic neisseria meningitidis serogroup a oligomer and process for synthesizing thereof
MX2021005949A (es) 2018-11-22 2021-07-06 Idorsia Pharmaceuticals Ltd Vacuna estable contra clostridium difficile.
CA3155669A1 (en) 2019-09-27 2021-04-01 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
CN118178643B (zh) * 2024-04-28 2024-11-29 亚培烯科技(上海)有限公司 饱和α烯烃低聚物作为佐剂在动物疫苗中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4356170A (en) * 1981-05-27 1982-10-26 Canadian Patents & Development Ltd. Immunogenic polysaccharide-protein conjugates
US6114309A (en) * 1997-11-21 2000-09-05 Incara Research Laboratories Combinatorial library of moenomycin analogs and methods of producing same
JP4774496B2 (ja) * 2001-06-14 2011-09-14 独立行政法人産業技術総合研究所 α−マンノシダーゼ
ES2616180T3 (es) * 2002-03-26 2017-06-09 Glaxosmithkline Biologicals Sa Sacáridos modificados con estabilidad mejorada en agua para su uso como medicamento
GB0220198D0 (en) 2002-08-30 2002-10-09 Chiron Spa Modified saccharides,conjugates thereof and their manufacture
DK1587537T3 (da) 2003-01-30 2012-07-16 Novartis Ag Injicerbare vacciner mod multiple meningococ-serogrupper
RU2250113C2 (ru) * 2003-06-04 2005-04-20 Институт биоорганической химии им. академиков М.М.Шемякина и Ю.А.Овчинникова Российской академии наук Способ приготовления бивалентной вакцины для профилактики менингококковой инфекции

Similar Documents

Publication Publication Date Title
RU2412944C2 (ru) Иммуногены для вакцин против менингита а
JP2013136639A5 (cg-RX-API-DMAC10.html)
JP2010515718A5 (cg-RX-API-DMAC10.html)
TWI633112B (zh) 醣類-醣脂類結合性疫苗
JP2010132925A5 (cg-RX-API-DMAC10.html)
JP2012017342A5 (cg-RX-API-DMAC10.html)
Enotarpi et al. A stabilized glycomimetic conjugate vaccine inducing protective antibodies against Neisseria meningitidis serogroup A
JP2005526153A5 (cg-RX-API-DMAC10.html)
AU2014289342B2 (en) Synthetic vaccines against Streptococcus pneumoniae type 1
CN107709343B (zh) 针对肺炎链球菌血清型5的疫苗
Torres‐Sanchez et al. Synthesis and biological evaluation of phosphono analogues of capsular polysaccharide fragments from Neisseria meningitidis A
Wright et al. Preparation of synthetic glycoconjugates as potential vaccines against Shigella flexneri serotype 2a disease
JPH0885703A (ja) 臓器移行性を有する多糖誘導体および薬物担体
Sukhova et al. Synthesis and preliminary immunological evaluation of a pseudotetrasaccharide related to a repeating unit of the Streptococcus pneumoniae serotype 6A capsular polysaccharide
JP4850377B2 (ja) リボース−リビトールホスフェートのオリゴ糖誘導体とそれを含むワクチン
AU2021331377B2 (en) Pentavalent vaccine against neisseria meningitidis comprising a synthetic men a antigen
CA3131741A1 (en) Carbocyclic derivatives and conjugated derivatives thereof, and their use in vaccines
JP2024180376A (ja) 化合物、免疫増強剤、ワクチン組成物及び粘膜ワクチン組成物
HK40113822A (en) Preventing/treating pseudomonas aeruginosa infection
Auberger Synthesis of Neisseria meningitidis serogroup A carba analogues as hydrolytically stable antigens for antimeningococcal glycoconjugate vaccines
CN119095871A (zh) 预防/治疗铜绿假单胞菌感染
Koutha Synthetic studies toward pseudopentasaccharide repeating unit of Streptococcus pneumoniae zwitterionic polysaccharide